Amneal, Shilpa receive FDA nod for Boruzu Boruzu is a ready-to-use oncology treatment used for multiple myeloma and mantle cell lymphoma. Alembic intros generic Luxiq FoamThe foam treats inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp. Evernorth to offer Stelara biosimilar at $0 out of pocket for patients early next year The estimated savings for individual Accredo patients is around $4,000 per year. Former FDA commissioner Janet Woodcock to headline AAM’s GRx+Biosims conference The conference takes place in Rockland, Md., Oct. 21-23. Lupin releases generic Myrbetriq Generic Myrbetriq is used to treat overactive bladder symptoms. NCPA pushes CMS for regulations outlining PBM contracting guardrails NCPA is urging CMS to eliminate abuses by plans and PBMs in Part D and ensure patient access to accurate information. AAM report: Generics, biosimilars generate $445B in savings Savings from biosimilar medicines alone increased to $12.4 billion in 2023 and $36 billion since the first biosimilar entry in 2015, according to AAM's latest report. Aurobindo receives FDA nod for generic Vagifem Estrodiol vaginal inserts are indicated for the treatment of atrophic vaginitis due to menopause. Hikma intros clindamycin in 5% dextrose injection The injection is indicated for the treatment of numerous infections. Lupin rolls out generic Doxil Generic Doxil is indicated for the treatment of ovarian cancer, acquired immune deficiency syndrome-related Kaposi’s Sarcoma and multiple myeloma. First Previous 22 23 24 25 26 Next Last
